Skip to main content

Volume 21 Supplement 1

The ethics of alternative clinical trial designs and methods in LMIC research: part two


Funds were provided by the Global Forum on Bioethics in Research (GFBR). GFBR funding is provided by the Wellcome Trust, the Bill & Melinda Gates Foundation [OPP1151904], the National Institutes of Health and the UK Medical Research Council. The GFBR and its funders had no role in the conception of the research or in writing the manuscripts. Peer review and editorial decisions regarding papers co-authored by PY and RvdG in this supplement were handled by an independent supplement editor. The Supplement Editors declare no other competing interests.

Bangkok, Thailand28-29 November 2017

Conference website

Edited by Ann-Margret Ervin, Phaik Yeong and Rieke van der Graaf

Related articles have been published as an earlier supplement to Trials.

  1. Cluster randomized trials are common in health research in low- and middle-income countries raising issues that challenge interpretation of standard ethical guidelines. While the Ottawa Statement on the ethica...

    Authors: Augustine T. Choko, Gholamreza Roshandel, Donaldson F. Conserve, Elizabeth L. Corbett, Katherine Fielding, Karla Hemming, Reza Malekzadeh and Charles Weijer
    Citation: Trials 2020 21(Suppl 1):314

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    2.5 - 5-year Impact Factor
    0.827 - SNIP (Source Normalized Impact per Paper)
    0.814 - SJR (SCImago Journal Rank)

    2022 Speed
    50 days submission to first editorial decision for all manuscripts (Median)
    188 days submission to accept (Median)

    2022 Usage 
    28,089 Altmetric mentions